Reply As your friend in the same pumpkin patch, you were one of the few people I told because you hear everything
Insurance companies scrambling to support need for GLP-1 drugs The overwhelming popularity of GLP-1 drugs what President Trump calls the fat shot has insurance companies scrambling to satisfy consumer access to the treatments while at the same time reining in their exorbitant costs
Insurance coverage varies significantly: Many insurance plans cover GLP-1s when prescribed for type 2 diabetes Coverage for weight management is less consistent and often requires meeting specific criteria (BMI thresholds, documented weight-related health conditions, prior weight loss attempts) Medicare Part D does not cover medications solely for weight loss Some manufacturers offer savings programs or patient assistance programs for eligible patients Check with your insurance provider about coverage criteria and explore manufacturer savings programs if paying out of pocket is a concern
With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures
Always follow your vet's guidance on frequency and dosage
Williams of Novo Nordisk A/S (Denmark) for medical writing support and Fraser Harris, MRes, of AXON Communications for editorial and submission support, funded by Novo Nordisk